1 – 6 of 6
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia (
- 2016
- Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients (
- 2015
- IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome. (
- 2013
- Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients (
- 2011
- Expansion of highly differentiated CD8(+) T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation (
- 2009
- Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy (